Clinical Significance of Soluble Major Histocompatibility Complex Class I Chain-related A in Renal Cell Carcinoma Patients |
Qiu, Yu
(Department of Urinary Surgery, The 2nd Affiliated Hospital of Harbin Medical University)
Zhao, Ya-Kun (Department of Urinary Surgery, The 2nd Affiliated Hospital of Harbin Medical University) Yuan, Gang-Jun (Department of Urinary Surgery, The 2nd Affiliated Hospital of Harbin Medical University) Zhu, Qing-Guo (Department of Urinary Surgery, The 2nd Affiliated Hospital of Harbin Medical University) |
1 | Groh V, Rhinehart R, Secrist H, et al (1999). Broad tumor-associated expression and recognition by tumor-derived gamma delta T cells of MICA and MICB. Proc Natl Acad Sci U S A, 96, 6879-84. DOI |
2 | Banumathy G, Cairns P (2010). Signaling pathways in renal cell carcinoma. Cancer Biol Ther, 10, 658-64. DOI ScienceOn |
3 | Bauer S, Groh V, Wu J, et al (1999). Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA. Science, 285, 727-9. DOI ScienceOn |
4 | Gasser S, Orsulic S, Brown EJ, Raulet DH (2005). The DNA damage pathway regulates innate immune system ligands of the NKG2D receptor. Nature, 436, 1186-90. DOI ScienceOn |
5 | Groh V, Bahram S, Bauer S, et al (1996). Cell stress-regulated human major histocompatibility complex class I gene expressed in gastrointestinal epithelium. Proc Natl Acad Sci U S A, 93, 12445-50. DOI ScienceOn |
6 | Groh V, Wu J, Yee C, Spies T (2002). Tumour-derived soluble MIC ligands impair expression of NKG2D and T-cell activation. Nature, 419, 734-8. DOI ScienceOn |
7 | Holdenrieder S, Stieber P, Peterfi A, et al (2006). Soluble MICA in malignant diseases. Int J Cancer, 118, 684-7. DOI ScienceOn |
8 | Jensen H, Andresen L, Nielsen J, Christensen JP, Skov S (2011). Vesicular stomatitis virus infection promotes immune evasion by preventing NKG2D-ligand surface expression. PLoS One, 6, e23023. DOI |
9 | Kohga K, Takehara T, Tatsumi T, et al (2009). Anticancer chemotherapy inhibits MHC class I-related chain a ectodomain shedding by downregulating ADAM10 expression in hepatocellular carcinoma. Cancer Res, 69, 8050-7. DOI ScienceOn |
10 | Zhao S, Wang H, Nie Y, et al (2012). Midkine upregulates MICA/B expression in human gastric cancer cells and decreases natural killer cell cytotoxicity. Cancer Immunol Immunother, 61, 1745-53. DOI ScienceOn |
11 | Kohga K, Takehara T, Tatsumi T, et al (2010). Sorafenib inhibits the shedding of major histocompatibility complex class I-related chain A on hepatocellular carcinoma cells by down-regulating a disintegrin and metalloproteinase 9. Hepatology, 51, 1264-73. DOI ScienceOn |
12 | Livak KJ, Schmittgen TD (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2 (-Delta Delta C(T)). Method Methods, 25, 402-8. DOI ScienceOn |
13 | Kohga K, Tatsumi T, Tsunematsu H, et al (2012). Interleukin- enhances the production of soluble MICA in human hepatocellular carcinoma. Cancer Immunol Immunother, 61, 1425-32. DOI ScienceOn |
14 | Lam JS, Leppert JT, Belldegrun AS, Figlin RA (2005). Novel approaches in the therapy of metastatic renal cell carcinoma. World J Urol, 23, 202-12. DOI ScienceOn |
15 | Li JJ, Pan K, Gu MF, et al (2013). Prognostic value of soluble MICA levels in the serum of patients with advanced hepatocellular carcinoma. Chin J Cancer, 32, 141-8. DOI |
16 | Madjd Z, Spendlove I, Moss R, et al (2007). Upregulation of MICA on high-grade invasive operable breast carcinoma. Cancer Immun, 7, 17. |
17 | Motzer RJ, Russo P (2000). Systemic therapy for renal cell carcinoma. J Urol, 163, 408-17. DOI ScienceOn |
18 | Oppenheim DE, Roberts SJ, Clarke SL, et al (2005). Sustained localized expression of ligand for the activating NKG2D receptor impairs natural cytotoxicity in vivo and reduces tumor immunosurveillance. Nat Immunol, 6, 928-37. DOI ScienceOn |
19 | Parkin DM, Bray F, Ferlay J, Pisani P (2005). Global cancer statistics, 2002. CA Cancer J Clin, 55, 74-108. DOI ScienceOn |
20 | Raffaghello L, Prigione I, Airoldi I, et al (2004). Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma. Neoplasia, 6, 558-68. DOI ScienceOn |
21 | Wang J, Li C, Yang D, Jian XC, Jiang CH (2012). Clinico-pathological significance of MHC-I type chain-associated protein A expression in oral squamous cell carcinoma. Asian Pac J Cancer Prev, 13, 715-8. 과학기술학회마을 DOI ScienceOn |
22 | Redova M, Poprach A, Nekvindova J, et al (2012). Circulating miR-378 and miR-451 in serum are potential biomarkers for renal cell carcinoma. J Transl Med, 10, 55. DOI ScienceOn |
23 | Salih HR, Holdenrieder S, Steinle A (2008). Soluble NKG2D ligands: prevalence, release, and functional impact. Front Biosci, 13, 3448-56. |
24 | Tamaki S, Sanefuzi N, Kawakami M, et al (2008). Association between soluble MICA levels and disease stage IV oral squamous cell carcinoma in Japanese patients. Hum Immunol, 69, 88-93. DOI ScienceOn |
25 | Watson NF, Spendlove I, Madjd Z, et al (2006). Expression of the stress-related MHC class I chain-related protein MICA is an indicator of good prognosis in colorectal cancer patients. Int J Cancer, 118, 1445-52. DOI ScienceOn |
26 | Weber KJ, Rao G, Quiros R, et al (2004). Increased expression of MICA in serum of pancreatic cancer patients. J Am Coll Surg, 199, 89. |
27 | Yamanegi K, Yamane J, Kobayashi K, et al (2012). Downregulation of matrix metalloproteinase-9 mRNA by valproic acid plays a role in inhibiting the shedding of MHC class I-related molecules A and B on the surface of human osteosarcoma cells. Oncol Rep, 28, 1585-90. |
28 | Mustafa A, Gupta S, Hudes GR, et al (2011). Serum amino acid levels as a biomarker for renal cell carcinoma. J Urol, 186, 1206-12. DOI ScienceOn |
29 | Duan X, Deng L, Chen X, et al (2011). Clinical significance of the immunostimulatory MHC class I chain-related molecule A and NKG2D receptor on NK cells in pancreatic cancer. Med Oncol, 28, 466-74. DOI ScienceOn |